BRIEF-Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update

Reuters12-18 22:12

BRIEF-Diamedica <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Provides Dm199 Preeclampsia Program Update

Dec 18 (Reuters) - DiaMedica Therapeutics Inc DMAC.O:

DIAMEDICA THERAPEUTICS PROVIDES DM199 PREECLAMPSIA PROGRAM UPDATE FOLLOWING PRE-IND MEETING WITH FDA
DIAMEDICA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL NON-CLINICAL STUDY FOR DM199
DIAMEDICA THERAPEUTICS INC - STUDY RESULTS EXPECTED BY Q2 2026

Source text: ID:nBw3sDzX1a

Further company coverage: DMAC.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592904880?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-18 22:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592904880","market":"fut","top_or_hot":-1,"title":"BRIEF-Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Diamedica <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Provides Dm199 Preeclampsia Program Update </title></head><body><p><span>Dec 18 (Reuters)</span><span> - </span>DiaMedica Therapeutics Inc <span>DMAC.O</span>:</p><ul><li><p>DIAMEDICA THERAPEUTICS PROVIDES DM199 PREECLAMPSIA PROGRAM UPDATE FOLLOWING PRE-IND MEETING WITH FDA</p></li><li><p>DIAMEDICA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL NON-CLINICAL STUDY FOR DM199</p></li><li><p>DIAMEDICA THERAPEUTICS INC - STUDY RESULTS EXPECTED BY <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2026</p></li></ul><p>Source text: <span>ID:nBw3sDzX1a</span></p><p>Further company coverage: <span>DMAC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-18 22:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Diamedica <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Provides Dm199 Preeclampsia Program Update </title></head><body><p><span>Dec 18 (Reuters)</span><span> - </span>DiaMedica Therapeutics Inc <span>DMAC.O</span>:</p><ul><li><p>DIAMEDICA THERAPEUTICS PROVIDES DM199 PREECLAMPSIA PROGRAM UPDATE FOLLOWING PRE-IND MEETING WITH FDA</p></li><li><p>DIAMEDICA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL NON-CLINICAL STUDY FOR DM199</p></li><li><p>DIAMEDICA THERAPEUTICS INC - STUDY RESULTS EXPECTED BY <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2026</p></li></ul><p>Source text: <span>ID:nBw3sDzX1a</span></p><p>Further company coverage: <span>DMAC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DMAC","symbol_name":"DiaMedica Therapeutics Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nTUA7WBSLD:1","article_id":"2592904880","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592904880","pubTimestamp":1766067122,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update Dec 18 (Reuters) - DiaMedica Therapeutics Inc DMAC.O:DIAMEDICA THERAPEUTICS PROVIDES DM199 PREECLAMPSIA PROGRAM UPDATE FOLLOWING","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DMAC":"DiaMedica Therapeutics Inc.","BK4139":"生物科技"},"translate_title":"简介-Diamedica Therapeutics提供Dm199先兆子痫项目更新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DMAC":0.9},"content_text":"BRIEF-Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update Dec 18 (Reuters) - DiaMedica Therapeutics Inc DMAC.O:DIAMEDICA THERAPEUTICS PROVIDES DM199 PREECLAMPSIA PROGRAM UPDATE FOLLOWING PRE-IND MEETING WITH FDADIAMEDICA THERAPEUTICS INC - FDA REQUESTS ADDITIONAL NON-CLINICAL STUDY FOR DM199DIAMEDICA THERAPEUTICS INC - STUDY RESULTS EXPECTED BY Q2 2026Source text: ID:nBw3sDzX1aFurther company coverage: DMAC.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592904880","isCrawlerRequest":true}